The 68th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery

Neutrophil Gelatinase-Associated lipocalin (NGAL) for the Assessment of Reversible vs. Persistent Renal Tubular Damage in ST-Segment Myocardial Infarction Patients

Ariel Banai Keren-Lee Rozenfeld Itamar Loewenstein David Zahler Moshe Shtark Ilana Goldiner Shmuel Banai Koby Shacham
Cardiology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Israel

Background: Most studies investigated the value of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a marker of renal tubular injury only at a single time point. We investigated the possible utilization of NGAL level dynamics for the identification of different renal injury patterns in ST elevation myocardial infarction (STEMI) patients.

Methods: Blood samples for plasma NGAL in 132 STEMI patients were drawn immediately before and 24 hours following primary coronary intervention. Abnormal elevation of NGAL levels were defined using the cardiac surgery associated NGAL score with NGAL levels ≥100ng/ml suggesting renal tubular damage. According to NGAL levels at 0 and 24 hours patients were stratified into 3 groups: no tubular damage (NGAL< 100 ng/ml in both exams), reversible tubular damage (NGAL>100 ng/ml at 0 hour but100 ng/ml at both 0 and 24 hours).

Results: Mean age was 62 ±13 years and 78% were men. Of these patients, 29/132 (22%) demonstrated reversible tubular damage, and 36/132 (27%) persistent tubular damage. Only 13/132 patients (10%) progressed to clinical acute kidney injury during hospitalization, all of whom had persistent tubular injury.). In multivariate regression model symptom duration was independently associated with persistent tubular damage, both as a continuous variable (OR 1.02, 95% CI 1.01-1.04;p=0.04) and for symptom duration>360 minutes (OR 2.66 ,95% CI 1.07-6.63;p=0.03).

Conclusions: Renal tubular damage is common among STEMI patients. Dynamic NGAL measurement may differentiate between reversible and persistent tubular damage. Further trials are needed in order to assess the complex cardio-renal interactions.









Powered by Eventact EMS